Liraglutide regulates the viability of pancreatic α-cells and pancreatic β-cells through cAMP-PKA signal pathway
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 195, 87-94
Abstract
No abstract availableKeywords
Funding Information
- Foshan Medical Science and Technology Research Project (2015AB00314)
This publication has 33 references indexed in Scilit:
- Study on therapeutic action of bone marrow derived mesenchymal stem cell combined with vitamin E against acute kidney injury in ratsLife Sciences, 2013
- MicroRNAs in somatic cell reprogrammingCurrent Opinion in Cell Biology, 2013
- Effects of liraglutide on postprandial insulin and glucagon responses in Japanese patients with type 2 diabetesJournal of Clinical Biochemistry and Nutrition, 2013
- Regulation of microRNA-375 by cAMP in Pancreatic β-CellsMolecular Endocrinology, 2012
- Early endocrine and molecular changes in metabolic syndrome modelsIUBMB Life, 2011
- Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical ImplicationsThe American Journal of Medicine, 2011
- Role of MicroRNA in Pancreatic β-CellsDiabetes, 2008
- miR-375 Targets 3′-Phosphoinositide–Dependent Protein Kinase-1 and Regulates Glucose-Induced Biological Responses in Pancreatic β-CellsDiabetes, 2008
- The biology of incretin hormonesCell Metabolism, 2006
- A pancreatic islet-specific microRNA regulates insulin secretionNature, 2004